Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
PGEN
PGEN
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
PGEN News
Precigen to Participate in H.C. Wainwright Virtual Fireside Chat
6d ago
PRnewswire
Precigen to Participate in Virtual Fireside Chat
6d ago
Newsfilter
Precigen Shares Surge 30% on Positive Q1 Revenue Outlook Despite Lower Financials
Mar 26 2026
seekingalpha
Precigen Inc Reports Strong Revenue Growth and Challenges in 2025 Earnings
Mar 26 2026
Yahoo Finance
Precigen Q4 2025 Earnings Call Highlights
Mar 25 2026
seekingalpha
Precigen (PGEN) Q4 2025 Earnings Call Transcript
Mar 25 2026
NASDAQ.COM
Precigen Reports 2025 Financial Results and Product Updates
Mar 25 2026
PRnewswire
Precigen Reports FY Non-GAAP EPS of -$1.37 with Revenue Growth
Mar 25 2026
seekingalpha
Precigen (PGEN) to Announce Q4 Earnings on March 25
Mar 24 2026
seekingalpha
Precigen Announces Full Year 2025 Financial Results Release Schedule
Mar 11 2026
PRnewswire
Precigen Announces PAPZIMEOS as New Standard of Care for RRP Treatment
Jan 20 2026
PRnewswire
Precigen Receives FDA Approval for PAPZIMEOS, Surpassing 200 Patient Registrations
Jan 12 2026
Newsfilter
Precigen CEO Helen Sabzevari to Present at 44th Annual J.P. Morgan Healthcare Conference
Jan 05 2026
PRnewswire
Ultragenyx Shares Plunge 42% Following Phase 3 Study Failures for Setrusumab
Dec 29 2025
Benzinga
DigitalBridge Group Inc Acquired by SoftBank Group for Approximately $4 Billion
Dec 29 2025
Benzinga
Promega Collaborates with Oxford to Accelerate Precision Medicine Research
Dec 09 2025
Businesswire
Show More News
